The 2023 Gartner Hype Cycle for Artificial Intelligence provides guidance on the innovation around artificial intelligence. Huma.AI has been cited amongst the premier vendors in generative AI, including Microsoft, Amazon, OpenAI and Hugging Face.
According to Gartner: “Generative artificial intelligence and ChatGPT have elevated AI discussions to new levels, pushing interest to boardrooms and heads of state alike. Data and analytics leaders must stay on top of the trends and track the trajectory of innovations to create credible cases for investment.”
Generative AI has profound business impacts, including on content discovery, creation, authenticity and regulations; automation of human work; and customer and employee experiences. Such impacts are particularly transformative for Healthcare and Life Sciences. Huma.AI’s generative AI platform for Life Sciences has revolutionized how companies accelerate the process of bringing life saving drugs to market.
Generative AI will progress rapidly in industry verticals, scientific discovery and technology commercialization such as life sciences. While the possibility exists that there are select security hurdles if the content is utilized for nefarious purposes, responsible AI will be necessary for safe exploitation of generative AI.
Also Read : Recruitics Unveils Vision: An AI-powered, Next-Generation Recruitment Analytics Platform
“We are honored that Gartner chose to cite us in this pivotal hype cycle as a leading generative AI provider for Life Sciences,” said Huma.AI Co-Founder and CEO Lana Feng. “We are excited to continue to innovate so that we can bring drugs to the market faster and save patient’s lives.”
Co-founded by Lana Feng Ph.D. and Greg Kostello, Huma.AI is a leading generative AI company offering a powerful and user-friendly NLP platform that turns life science domain experts into their own data scientists. The name Huma means human plus machine where humans always come first. Its transformative, human-centric AI platform has garnered tremendous industry recognition, and Huma.AI currently works with many pharmaceutical and medical device and IVD companies across the globe.
Huma.AI is a pioneer in generative AI, providing its own “ChatGPT” for life sciences through direct collaboration with OpenAI. Its medical affairs solution allows Medical Affairs teams to obtain previously unknown intelligence that is critical for HCP engagement and medical strategy. Huma.AI begins where ChatGPT ends: The platform analyzes across disparate sources, including internal data and external data; provides references and explanations for experts’ verification and validation; its “expert-in-the-loop” approach leads to the highest accuracy possible. Huma.AI’s mission is to empower life science professionals with mission critical decision-making data, insights, and analysis using everyday language.
SOURCE : PRWeb
Comments are closed.